Trends in the use of Cephamycin in Taiwanese inpatients

• Main Authors: Ying-Yi Chen, 陳穎儀
• Other Authors: Thau-Ming Cham
• Format: Others
• Language: zh-TW
• Published: 2005
• Online Access: http://ndltd.ncl.edu.tw/handle/82078280563862593769

碩士 === 高雄醫學大學 === 藥學研究所碩士班 === 93 === Objectives The major purpose of this study was to analyze cefotetan、cefoxitin and cefmetazole utilization and trends for Taiwanese inpatients, from 1997 to 2001. We analyzed the utilization and long-term trends within patient’s social demography（age, sex）and medical care institution’s characteristics（branch local, hospital level）, and the usage situation of every month. Methods Data source was derived from“inpatients expenses claims data, inpatients order claim data, and medical care institutional files in National Health Insurance Research Database from 1997 to 2001. According these data files, we selected cefotetan、cefoxitin and cefmetazole for analysis. The total number of patients were 4345, and among these patients，cefoxitin was 1938, cefmetazole was 2407. SAS for Windows 8.2 was used for data management and statistic analysis, and undered the usage trends of cefotetan、cefoxitin and cefmetazole variety by analyzing the result. Results Results of the study indicated that increasing used cefoxitin and cefmetazole from 1997 to 2001. Cefoxitin used 307 patients in 1997 to 484 patients in 2001, and Cefmetazole used 468 patients in 1997 to 551 patients in 2001. In part of age and sex, cefoxitin used the most in above 65-year-old male, but cefmetazole used the most in above 65-year-old female. In part of month, cefoxitin used the most in July, and cefmetazole used the most in February. In the aspect of medical level, cefoxitin and cefmetazole both used most in medical centers, cefoxitin and cefmetazole were decreasing trends use to decreasing level of the institutions. In the aspect of branch local, cefoxitin and cefmetazole both used in Taipei Branch more than other branchs. So for this reason cefoxitin and cefmetazole usage were some differences. Conclusions Although the usage quantity of cefotetan、cefoxitin and cefmetazole at Taiwan did not be regarded as at most, but we could find that the usage still had some difference from the results. So clinicians who should use cefoxitin and cefmetazole wit caution, and could tell patients correct the medicinal methods, thus could reduce resistance and abuse.